Literature DB >> 18239867

Depth of tumor invasion in locally advanced rectal cancer correlates with patients' prognosis: the usefulness of elastic stain for its measurement.

Daisuke Katsumata1, Hirokazu Fukui, Yuko Ono, Kazuhito Ichikawa, Shigeki Tomita, Johji Imura, Akihito Abe, Masanori Fujita, Osamu Watanabe, Masahiro Tsubaki, Masakatsu Sunagawa, Takahiro Fujimori.   

Abstract

PURPOSE: The relationship between the prognosis and the extent of colorectal carcinoma (CRC) is still unclear. As a simple parameter of the local invasion of CRC, we assessed the extent of tumor invasion beyond the outer border of the muscularis propria (MP).
METHODS: We examined 147 cases of CRC using a slight modification of the procedure established by the Japanese Society for Cancer of the Colon and Rectum. For the statistical analysis, the patients were divided into two groups, namely, a "shallow" group and a "deep" group, using a specific cut-off value (COV). A multivariate analysis to identify independent prognostic factors was performed.
RESULTS: Significant differences in the 5-year survival rate were observed between the "shallow" and "deep" groups in 39 cases of rectal carcinoma (COV 4 mm; 72.4% vs. 30.0%, hazard ratio = 3.204), but not observed in 147 cases of CRC. In addition, the outcome for patients with "deep" cancer in the lower rectum was markedly worse than that for patients with "shallow" cancer (COV 4 mm; 81.8% vs. 12.5%, hazard ratio = 5.371).
CONCLUSIONS: The depth of tumor invasion beyond the MP is thus considered to be an important prognostic factor for patients with T3/T4 rectal carcinoma, especially in the lower rectum. A careful follow-up is required for the patients with rectal carcinoma that has invaded more than 4 mm beyond the MP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18239867     DOI: 10.1007/s00595-007-3608-3

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  12 in total

1.  The prognostic significance of direct extension of carcinoma of the colon and rectum.

Authors:  V B ASTLER; F A COLLER
Journal:  Ann Surg       Date:  1954-06       Impact factor: 12.969

2.  Risk factors for an adverse outcome in early invasive colorectal carcinoma.

Authors:  Hideki Ueno; Hidetaka Mochizuki; Yojiro Hashiguchi; Hideyuki Shimazaki; Shinsuke Aida; Kazuo Hase; Susumu Matsukuma; Tadao Kanai; Hiroyuki Kurihara; Kotaro Ozawa; Kazuyoshi Yoshimura; Shinya Bekku
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

3.  Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: a Japanese collaborative study.

Authors:  Kazuaki Kitajima; Takahiro Fujimori; Shigehiko Fujii; Jun Takeda; Yasuo Ohkura; Hitoshi Kawamata; Toshihide Kumamoto; Shingo Ishiguro; Yo Kato; Tadakazu Shimoda; Akinori Iwashita; Yoichi Ajioka; Hidenobu Watanabe; Toshiaki Watanabe; Tetsuichiro Muto; Ko Nagasako
Journal:  J Gastroenterol       Date:  2004-06       Impact factor: 7.527

4.  High-risk groups of patients with Stage II colon carcinoma.

Authors:  S Merkel; A Wein; K Günther; T Papadopoulos; W Hohenberger; P Hermanek
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

5.  Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

Authors:  H Ueno; J Murphy; J R Jass; H Mochizuki; I C Talbot
Journal:  Histopathology       Date:  2002-02       Impact factor: 5.087

6.  Extent of mesorectal invasion is a prognostic indicator in T3 rectal carcinoma.

Authors:  Malcolm C A Steel; Rodney Woods; Jack M Mackay; Frank Chen
Journal:  ANZ J Surg       Date:  2002-07       Impact factor: 1.872

7.  Prognostic significance of depth of gross or microscopic perirectal fat invasion in T3 N0 M0 rectal cancers following sharp mesorectal excision and no adjuvant therapy.

Authors:  Antonio I Picon; Harvey G Moore; Stephen S Sternberg; Bruce D Minsky; Philip B Paty; David Blumberg; Stuart H Quan; W Douglas Wong; Alfred M Cohen; Jose G Guillem
Journal:  Int J Colorectal Dis       Date:  2003-06-03       Impact factor: 2.571

8.  The value of an elastic tissue stain in detecting venous invasion in colorectal cancer.

Authors:  D G Vass; R Ainsworth; J H Anderson; D Murray; A K Foulis
Journal:  J Clin Pathol       Date:  2004-07       Impact factor: 3.411

9.  The subserosal elastic lamina: an anatomic landmark for stratifying pT3 colorectal cancer.

Authors:  Eiji Shinto; Hideki Ueno; Yojiro Hashiguchi; Kazuo Hase; Hitoshi Tsuda; Osamu Matsubara; Hidetaka Mochizuki
Journal:  Dis Colon Rectum       Date:  2004-03-04       Impact factor: 4.585

10.  Extent of mesorectal tumor invasion as a prognostic factor after curative surgery for T3 rectal cancer patients.

Authors:  Masayoshi Miyoshi; Hideki Ueno; Yojiro Hashiguchi; Hidetaka Mochizuki; Ian C Talbot
Journal:  Ann Surg       Date:  2006-04       Impact factor: 12.969

View more
  10 in total

1.  Aggressive undifferentiated colon carcinoma producing granulocyte-colony stimulating factor: report of a case.

Authors:  Akihisa Matsuda; Koji Sasajima; Takeshi Matsutani; Hiroshi Maruyama; Masayuki Miyamoto; Tadashi Yokoyama; Seiji Suzuki; Hideyuki Suzuki; Takashi Tajiri
Journal:  Surg Today       Date:  2009-11-01       Impact factor: 2.549

2.  Acid-mediated tumour cell invasion: a discrete modelling approach using the extended Potts model.

Authors:  Maymona Al-Husari; Steven D Webb
Journal:  Clin Exp Metastasis       Date:  2013-03-31       Impact factor: 5.150

3.  Better prognostic determination of cT3 rectal cancer through measurement of distance to mesorectal fascia: A multicenter study.

Authors:  Xiaoyan Zhang; Qiaoyuan Lu; Xiangjie Guo; Wuteng Cao; Hongmei Zhang; Tao Yu; Xiaoting Li; Zhen Guan; Xueping Li; Ruijia Sun; Yingshi Sun
Journal:  Chin J Cancer Res       Date:  2021-10-31       Impact factor: 4.026

4.  Transrectal ultrasound and magnetic resonance imaging measurement of extramural tumor spread in rectal cancer.

Authors:  Søren R Rafaelsen; Chris Vagn-Hansen; Torben Sørensen; John Pløen; Anders Jakobsen
Journal:  World J Gastroenterol       Date:  2012-09-28       Impact factor: 5.742

5.  Association between histological type of tumour growth and patient survival in t2-t3 lymph node-negative rectal cancer treated with sphincter-preserving total mesorectal excision.

Authors:  Bartlomiej Szynglarewicz; Rafal Matkowski; Agnieszka Halon; Aleksandra Lacko; Marcin Stepien; Jozef Forgacz; Marek Pudelko; Jan Kornafel
Journal:  Pathol Oncol Res       Date:  2009-09-15       Impact factor: 3.201

6.  Prognostic significance of a preoperative magnetic resonance imaging assessment of the distance of mesorectal extension in clinical T3 lower rectal cancer.

Authors:  Toshinori Sueda; Masayuki Ohue; Shingo Noura; Tatsushi Shingai; Katsuyuki Nakanishi; Masahiko Yano
Journal:  Surg Today       Date:  2016-01-14       Impact factor: 2.549

7.  Does t3 subdivision correlate with nodal or distant metastasis in colorectal cancer?

Authors:  Hong Yeol Yoo; Rumi Shin; Heon-Kyun Ha; Heung-Kwon Oh; Seung-Yong Jeong; Kyu Joo Park; Gyeong Hoon Kang; Woo Ho Kim; Jae-Gahb Park
Journal:  J Korean Soc Coloproctol       Date:  2012-06-30

8.  Histopathology and enhanced detection of tumor invasion of peritoneal membranes.

Authors:  Jey-Hsin Chen; Melissa Borges
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

9.  The prognostic significance of MRI-detected extramural venous invasion, mesorectal extension, and lymph node status in clinical T3 mid-low rectal cancer.

Authors:  Chaoyang Gu; Xuyang Yang; Xubing Zhang; Erliang Zheng; Xiangbing Deng; Tao Hu; Qingbin Wu; Liang Bi; Bing Wu; Minggang Su; Ziqiang Wang
Journal:  Sci Rep       Date:  2019-08-29       Impact factor: 4.379

10.  Benefit of the measurement of mesorectal extension in patients with pT3N1-2 rectal cancer without pre-operative chemoradiotherapy: Post-operative treatment strategy.

Authors:  Yoshito Akagi; Kazuo Shirouzu; Shin Fujita; Hideki Ueno; Yasumasa Takii; Koji Komori; Masaaki Ito; Kenichi Sugihara
Journal:  Exp Ther Med       Date:  2012-12-14       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.